Polyomavirus inactivation - A review

Biologicals

Volumn 41, Issue 2, 2013, Pages 63-70

  Nims, Raymond W ^a   Plavsic, Mark ^b  

^a RMC Pharmaceutical Solutions Inc   (United States)

^b SANOFI   (France)

Author keywords

Avian polyomavirus; BK virus; Disinfectant chemical inactivation; Gamma irradiation; Heat inactivation; JC virus; Low pH inactivation; Mouse polyomavirus; Photodynamic inactivation; SV40; UV C irradiation; Viral inactivation; X irradiation

Indexed keywords

ACRIDINE ORANGE; ALCOHOL; BIOLOGICAL PRODUCT; DISINFECTANT AGENT; FORMALDEHYDE; METHYLENE BLUE; PROPIOLACTONE; SODIUM HYDROXIDE; TOLONIUM CHLORIDE;

ACIDITY; CARCINOGENICITY; DISINFECTION; DRUG CONTAMINATION; GAMMA IRRADIATION; HEATING; HUMAN; IONIZING RADIATION; NONHUMAN; PH; PHOTODYNAMICS; POLYOMA VIRUS; PRIORITY JOURNAL; REVIEW; SIMIAN VIRUS 40; ULTRAVIOLET C RADIATION; VIRUS INACTIVATION; VIRUS INFECTIVITY;

ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; VIRUS INACTIVATION;

AVES; BK POLYOMAVIRUS; JC POLYOMAVIRUS; MURINE POLYOMAVIRUS; PARVOVIRUS; POLYOMAVIRUS;

EID: 84875279754     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2012.09.011     Document Type: Review

References (87)

1. Krumbholz A., Bininda-Emonds O.R.P., Wutzler P., Zell R. Phylogenetics, evolution, and medical importance of polyomaviruses. Infect Genet Evol 2009, 9:784-799.
2. Kean J.M., Rao S., Wang M., Garcea R.L. Seroepidemiology of human polyomaviruses. PLoS Pathog 2009, 5:1-10.
3. Fagrouch Z., Karremans K., Deuzing I., van Gessel S., Niphuis H., Bogers W., et al. Molecular analysis of a novel simian virus 40 (SV40) type in rhesus macaques and evidence for double infections with the classical SV40 type. J Clin Microbiol 2011, 49:1280-1286.
4. Garcea R.L., Imperiale M.J. Simian virus 40 infection of humans. J Virol 2003, 77:5039-5045.
5. Strickler H.D. Simian virus 40 (SV40) and human cancers. Einstein Quart J Biol Med 2001, 18:14-20.
6. Shuurman R., van Steenis B., van Strien A., van der Noordaa J., Sol C. Frequent detection of bovine polyomavirus in commercial batches of calf serum by using the polymerase chain reaction. J Gen Virol 1991, 72:2739-2745.
7. European Agency for the Evaluation of Medicinal Products. Note for guidance on the use of bovine serum in the manufacture of human biological medicinal products. CPMP/BWP/1793/02. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003675.pdf.
8. Kappeler A., Lutz-Wallace C., Sapp T., Sidhu M. Detection of bovine polyomavirus contamination in fetal bovine sera and modified live viral vaccines using polymerase chain reaction. Biologicals 1996, 24:131-135.
9. Pérez-Losada M., Christensen R.G., McClellan D.A., Adams B.J., Viscidi R.P., Demma J.C., et al. Comparing phylogenic codivergence between polyomaviruses and their hosts. J Virol 2006, 80:5663-5669.
10. Parry J.V., Gardner S.D. Human exposure to bovine polyomavirus: a zoonosis?. Ach Virol 1986, 87:287-296.
11. Eddy B.E., Stewart S.E., Grubbs G.E. Influence of tissue culture passage, storage, temperature and drying on viability of S E polyoma virus. Proc Soc Exp Biol Med 1958, 99:289-292.
12. Brodsky I., Rowe W.P., Hartley J.W., Lane W.T. Studies of mouse polyoma virus infection. II. Virus stability. J Exp Med 1959, 109:439-447.
13. Lewis A.M., Prigge K.O., Rowe W.P. Studies of adenovirus-SV40 hybrid viruses: IV. An adenovirus type 2 strain carrying the infectious SV40 genome. Proc Natl Acad Sci USA 1966, 55:526-531.
14. Bozeman L.H., Davis R.B., Gaudry D., Lukert P.D., Fletcher O.J., Dykstra M.J. Characterization of a papovavirus isolated from fledgling budgerigars. Avian Dis 1981, 25:972-980.
15. Lelie P.N., Reesink H.W., Lucas C.J. Inactivation of 12 viruses by heating steps applied during manufacture of a hepatitis B vaccine. J Med Virol 1987, 23:297-301.
16. Ritchie B.W., Pritchard N., Pesti D., Niagro F.D., Latimer K.S., Lukert P.D. Susceptibility of avian polyomavirus to inactivation. J Assoc Avian Vet 1993, 7:193-195.
17. Sauerbrei A., Wutzler P. Testing thermal resistance of viruses. Arch Virol 2009, 154:115-119.
18. Roberts P.L., More J., Rott J., Lewin D. Virus inactivation in albumin by a combination of alkali conditions and high temperature. Biologicals 2011, 39:67-72.
19. Schleh M., Romanowski P., Bhebe P., Zhang L., Chinniah S., Lawrence B., et al. Susceptibility of mouse minute virus to inactivation by heat in two cell culture media types. Biotechnol Prog 2009, 25:854-860.
20. Schleh M., Lawrence B., Park T., Rosenthal S., Hart R., Dehghani H. Effectiveness of upstream barrier technologies for inactivation of adventitious contaminants of cell culture. Am Pharm Rev 2010, 13:72-76.
21. Weaver B., Rosenthal S. Viral risk mitigation for mammalian cell culture media. PDA J Pharm Sci Technol 2010, 64:436-439.
22. Murphy M., Quesada G.M., Chen D. Effectiveness of mouse minute virus inactivation by high temperature short time treatment technology: a statistical assessment. Biologicals 2011, 39:438-443.
23. 40) by formaldehyde. Proc Soc Exp Biol Med 1961, 108:205-209.
24. Truffelli G.T., Timm E.A., Beardmore W.B., McLean I.W. Inactivation of adenovirus and simian virus 40 tumorigenicity in hamsters by vaccine processing methods. Appl Microbiol 1967, 15:516-527.
25. Brown A., Consigli R.A., Zabielski J., Weil R. Effect of β-propiolactone inactivation of polyoma virus on viral functions. J Virol 1974, 14:840-845.
26. Pitko V.-M., Pyökäri P., Näse L., Mäntyjärvi R. Effect of β-propiolactone on infectivity and haemagglutinin of the BK virus. Acta Path Microbiol Scand Sect B Microbiol 1975, 83B:141-144.
27. Dichtelmüller H., Rudnick D., Breuer B., Gänshirt K.H. Validation of virus inactivation and removal for the manufacturing procedure of two immunoglobulins and a 5% serum protein solution treated with β-propiolactone. Biologicals 1993, 21:259-268.
28. Scheidler A., Rokos K., Reuter T., Ebermann R., Pauli G. Inactivation of viruses by β-propiolactone in human cryo poor plasma and IgG concentrates. Biologicals 1998, 26:135-144.
29. Lawrence S.A. β-Propiolactone: viral inactivation in vaccines and plasma products. PDA J Pharm Sci Technol 2000, 54:209-217.
30. Sofer G. Virus inactivation in the 1990s - and into the 21st century part 3b, plasma and plasma products (treatments other than heat or solvent/detergent). BioPharm Int 2002, Oct:42-51.
31. Benjamin T.L. Relative target sizes for the inactivation of the transforming and reproductive abilities of polyoma virus. Proc Natl Acad Sci USA 1965, 54:121-124.
32. GE Healthcare Use of sodium hydroxide for cleaning and sanitizing chromatography media and systems 2008, GE Healthcares application note 18-1124-57 AG. http://www.gelifesciences.com/aptrix/upp00919.nsf/Content/79D9F599C4580FAAC1257628001CCBD6/$file/18112457AG.pdf.
33. Schürmann W., Eggers H.J. Antiviral activity of an alcoholic hand disinfectant. Comparison of the in vitro suspension test with in vivo experiments on hands, and on individual fingertips. Antiviral Res 1983, 3:25-41.
34. Eggers H.J. Experiments on antiviral activity of hand disinfectants. Some theoretical and practical considerations. Zentralbl Bakteriol 1990, 273:36-51.
35. Bélec L., Tevi-Benissan C., Bianchi A., Cotigny S., Beumont-Mauviel M., Si-Mohamed A., et al. In vitro inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2, CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by the spermicide benzalkonium chloride. J Antimicrob Chemother 2000, 46:685-693.
36. Engelbrecht R.S., Weber M.J., Salter B.L., Schmidt C.A. Comparative inactivation of viruses by chlorine. Appl Environ Microbiol 1980, 40:249-256.
37. Steinmann J. Evaluation of the effectiveness of eradic8 A2Z against polyomavirus SV40 2006, MikroLab GmbH project number C05ML260. http://www.ebiox.co.uk/images/uploads/eradic8_A2Z_SV40_09_03_2006.pdf.
38. Snipes W., Person S., Keller G., Taylor W., Keith A. Inactivation of lipid-containing viruses by long-chain alcohols. Antimicrob Agents Chemother 1977, 11:98-104.
39. Fina L.R., Hassouna N., Horacek G.L., Lambert J.P., Lambert J.L. Viricidal capability of resin-triiodide demand-type disinfectant. Appl Environ Microbiol 1982, 44:1370-1373.
40. Westcott D.G.F., Ticehurst J., Chaplin M., Lukey J.R., Lucas M. The isolation of a virus resembling a polyomavirus from normal calves. Vet Microbiol 1987, 15:175-180.
41. Bos O.J.M., Sunyé D.G.J., Nieuweboer C.E.F., van Engelenburg F.A.C., Schuitemaket H., Over J. Virus validation of pH 4-treated human immunoglobulin products produced by the Cohn fractionation process. Biologicals 1998, 26:267-276.
42. Dubreuil R., Chagnon A., Pavilanis V. Résistance comparée des virus poliomyélitique, herpétique, spumeux et SV-40 á l'acidité. Can J Microbiol 1963, 9:359-367.
43. Gregersen J.P., Roth B. Inactivation of stable viruses in cell culture facilities by paracetic acid fogging. Biologicals 2012, 40:282-287.
44. Nims R., Plavsic M. Circovirus inactivation: a literature review. BioProcess J 2012, 11:4-10.
45. Lytle C.D., Sagripanti J.-L. Predicted inactivation of viruses of relevance to biodefense by solar radiation. J Virol 2005, 79:14244-14252.
46. Maier I. Inactivation of bacteria, viruses and other pathogens by UVC irradiation in the Leica cryostat product family. ECOscope 2007, 1-17. http://www.leica-microsystems.com/fileadmin/downloads/Leica%2520CM1950/Certificates/Leica_CM_UVC_Certificate_Bacteria.pdf.
47. Kowalski W.J., Bahnfleth W.P., Hernandez M.T. A genomic model for predicting the ultraviolet susceptibility of viruses. IUVA News 2009, 11:15-28.
48. Carp R.I., Gilden R.V. The inactivation of simian virus 40 infectivity and antigen-inducing capacity by ultraviolet light. Virology 1965, 27:639-641.
49. Rauth A.M. The physical state of viral nucleic acid and the sensitivity of viruses to ultraviolet light. Biophys J 1965, 5:257-273.
50. Butel J.S., Rapp F. Inactivation and density studies with para-adenovirus 7 (SV40-adenovirus 'hybrid' population). J Immunol 1966, 97:546-553.
51. Defendi V., Jensen F. Oncogenicity by DNA tumor viruses: enhancement after ultraviolet and cobalt-60 radiations. Science 1967, 157:703-705.
52. Latarjet R., Cramer R., Montagnier L. Inactivation, by UV-, X-, and γ-radiations, of the infecting and transforming capacities of polyoma virus. Virology 1967, 33:104-111.
53. van der Eb A.J., Cohen J.A. The effect of UV-irradiation on the plaque-forming ability of single- and double-stranded polyoma virus DNA. Biochem Biophys Res Commun 1967, 28:284-293.
54. Coppey J., Wicker R. Inactivation par les radiations U.V., X et gamma de deux proprietes du virus SV-40: infectivete et induction de lantigene nucleaire precoce. Ann Inst Pasteur 1968, 115:478-485.
55. Herberman R.B., Ting R.C. Dissociation of multiple polyoma virus functions by ultraviolet radiation. Proc Soc Exp Biol Med 1969, 131:461-464.
56. Aaronson S.A. Effect of ultraviolet irradiation on the survival of simian virus 40 functions in human and mouse cells. J Virol 1970, 6:393-399.
57. Meyer G., Birg F. Sensitivity to inactivation by ultraviolet light of certain functions of polyoma virus: cell surface antigen. J Gen Virol 1970, 9:127-131.
58. Yamamoto H., Shimojo H. Inactivation of T antigen-forming capacities of simian virus 40 and adenovirus 12 by ultraviolet irradiation. J Virol 1971, 7:419-425.
59. Seemayer N.H., Defendi V. Analysis of minimal functions of simian virus 40. II. Enhancement of oncogenic transformation in vitro by UV irradiation. J Virol 1973, 12:1265-1271.
60. Sarasin A.R., Hanawalt P.C. Carcinogens enhance survival of UV-irradiated simian virus 40 in treated monkey kidney cells: induction of a recovery pathway. Proc Natl Acad Sci USA 1978, 75:346-350.
61. Cameron K.R., Tomkins L.M., Eglin R.P., Ross L.J.N., Wildy P., Russell W.C. The effects of ultraviolet and ionizing radiation on herpesviruses, SV40 and adenoviruses in relation to the small-plaque effect. Arch Virol 1979, 62:31-40.
62. Deák II, Defendi V. Effects of discrete nuclear UV-microbeam irradiation on herpes virus and SV40 infection. J Cell Sci 1975, 17:531-538.
63. Cornelis J.J., Su Z.Z., Ward D.C., Rommelaere J. Indirect induction of mutagenesis of intact parvovirus H-1 in mammalian cells treated with UV light or with UV-irradiated H-1 or simian virus 40. Proc Natl Acad Sci USA 1981, 78:4480-4484.
64. Brown T.C., Cerutti P.A. Ultraviolet radiation inactivates SV40 by disrupting at least four genetic functions. EMBO J 1986, 5:197-203.
65. Kallenbach N.R., Cornelius P.A., Negus D., Montgomerie D., Englander S. Inactivation of viruses by ultraviolet light. Curr Stud Hematol Blood Transfus 1989, 56:70-82.
66. Wang J., Mauser A., Chao S.-F., Remington K., Treckmann R., Kaiser K., et al. Virus inactivation and protein recovery in a novel ultraviolet-C reactor. Vox Sang 2004, 86:230-238.
67. Terpstra F.G., van't Wout A.B., Schuitemaker H., van Engelenburg F.A.C., Dekkers D.W.C., Verhaar R., et al. Potential and limitation of UVC irradiation for the inactivation of pathogens in platelet concentrates. Transfusion 2008, 48:304-313.
68. Wallis C., Melnick J.L. Photodynamic inactivation of animal viruses: a review. Photochem Photobiol 1965, 4:159-170.
69. 40. Proc Soc Exp Biol Med 1962, 109:230-232.
70. Mayor H.D., Jamison R.M., Jordan L.E. Biophysical studies on the nature of the simian papova virus particle (vacuolating SV40 virus). Virology 1963, 19:359-366.
71. Rapp F., Li J.-L.H., Jerkofsky M. Transformation of mammalian cells by DNA-containing viruses following photodynamic inactivation. Virology 1973, 55:339-346.
72. Mohr H., Lambrecht B., Schmitt H. Photo-inactivation of viruses in therapeutical plasma. Dev Biol Stand 1993, 81:177-183.
73. Mohr H., Lambrecht B., Selz A. Photodynamic virus inactivation of blood components. Immunol Invest 1995, 24:73-85.
74. Williamson L.M., Cardigan R., Prowse C.V. Methylene blue-treated fresh-frozen plasma: what is its contribution to blood safety?. Transfusion 2003, 43:1322-1329.
75. Basilico C., di Mayorca G. Radiation target size of the lytic and the transforming ability of polyoma virus. Proc Natl Acad Sci USA 1965, 54:125-127.
76. Logan D.M., Whitmore G.F. Radiation effects on polyoma virus. Virology 1965, 25:495-501.
77. Sullivan R., Fassolitis A.C., Larkin E.P., Read R.N., Peeler J.T. Inactivation of thirty viruses by gamma radiation. Appl Microbiol 1971, 22:61-65.
78. Ginoza W. Inactivation of viruses by ionizing radiation and heat. Methods in virology 1968, vol. 4:139-209. Academic Press, Inc., New York.
79. Gauvin G., Nims R. Gamma-irradiation of serum for the inactivation of adventitious contaminants. PDA J Pharm Sci Technol 2010, 64:432-435.
80. Nims R.W., Gauvin G., Plavsic M. Gamma irradiation of animal sera for inactivation of viruses and mollicutes - a review. Biologicals 2011, 39:370-377.
81. Nathans D. A molecular approach to carcinogenesis: dissecting the genome of a small tumor virus. Johns Hopkins Med J 1976, 139:99-120.
82. International Conference on Harmonisation Q5A (R1). Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin. 1997. EMEA CPMP/ICH/295/95. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002801.pdf.
83. Guideline on virus safety evaluation of biotechnological investigational medicinal products 2008, EMEA/CHMP/BWP/398498/2005. http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003795.pdf.
84. Dall A., Hariharan S. BK virus nephritis after renal transplantation. Clin J Am Soc Nephrol 2008, 3:S68-S75.
85. Khalili K., White M.K., Lublin F., Ferrante P., Berger J.R. Reactivation of JC virus and development of PML in patients with multiple sclerosis. Neurology 2007, 68:985-990.
86. Wetzels C.T.A.H., Hoefnagel J.G.M., Bakkers J.M.J.E., Dijkman H.B.P.M., Blokx W.A.M., Melchers W.J.G. Ultrastructural proof of polyomavirus in Merkle cell carcinoma tumour cells and its absence in small cell carcinoma of the lung. PLoS One 2009, 4:1-5.
87. Gaynor A.M., Nissen M.D., Whiley D.M., Mackay I.M., Lambert S.B., Wu G., et al. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathogens 2007, 3:595-603.